Five9 Assists International Medical Device Enterprise to Move to the Cloud within 48 Hours

Apr 14, 2020 09:00 am

SAN RAMON, Calif. --

Five9, Inc. (NASDAQ: FIVN), a leading cloud contact center provider, today announced that the company enabled a major international medical device manufacturer to move their insurance verification operations to the cloud in under 48 hours.

In 2019, Five9 successfully migrated the customer’s global human resources operations, located in Europe, Asia, South America, and the United States, to the cloud. As the COVID-19 crisis escalated, the company’s other contact centers struggled to support agents working from home due to their on-premise solutions – especially, their insurance verification group.

Due to the smooth rollout of their HR division, the company asked to quickly migrate their insurance verification group to the Five9 Intelligent Cloud Contact Center. Within 48 hours, the insurance verification division’s agents were live on Five9 and fully enabled to operate from home.

“We are proud that in a time of need our customer came to us for help knowing that they could trust Five9 to get the job done,” said Dan Burkland, Five9 President. “Our commitment to providing fast, scalable and reliable contact center solutions has never been more important, especially in these uncertain times where our customers need us the most. We are here to help keep people working, connected and safe.”

To learn about the Five9 FastTrack program, click here.

About Five9

Five9 is a leading provider of cloud contact center software for the intelligent contact center space, bringing the power of cloud innovation to customers and facilitating more than six billion call minutes annually. Five9 provides end-to-end solutions with omnichannel routing, analytics, WFO and AI to increase agent productivity and deliver tangible business results. The Five9 Genius platform is reliable, secure, compliant and scalable; designed to create exceptional personalized customer experiences.

For more information, visit www.five9.com.

Engage with us @Five9, LinkedIn, Facebook, Blog, That’s Genius Podcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200414005236/en/

Five9
Kendall Taylor
925-231-2196
[email protected]

Return to Top

Disclaimer :: Use of this site is subject to, and your continued use constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information. INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion; however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR® or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment. Users should always consult with and obtain advice from their professional licensed financial advisor, including their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment or trading securities do so with caution. Users should perform full due diligence and investigate any security fully before making an investment or before the execution of a security trade based upon information learned through INK. Investors should obtain annual reports and other company information to complete their own due diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this website. On this site, there may be third party content, content from authors or links to third-party sites or pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI® is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.

Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.

You are here

Five9 Assists International Medical Device Enterprise to Move to the Cloud within 48 Hours